Sherry Aulin | CFO |
Ian Mortimer | President and CEO |
Dr. Chris Kenney | CMO |
Dr. Chris Von Seggern | Chief Commercial Officer |
Tessa Romero | J.P. Morgan |
Paul Matteis | Stifel |
Brian Abrahams | RBC Capital Markets |
Andrew Tsai | Jefferies |
Paul Choi | Goldman Sachs |
Joseph Thome | TD Cowen |
Danielle Brill | Raymond James |
Laura Chico | Wedbush Securities |
Mohit Bansal | Wells Fargo |
Elaine Kim | Cantor Fitzgerald |
Tim Lugo | Williams Blair |
Good afternoon ladies and gentlemen, and thank you for standing by. Welcome to the Xenon Pharmaceuticals Report, Second Quarter 2023 Results Conference Call. At this time, all participants are in a listen-only mode. [Operator instructions].
I will now turn the call over to Sherry Aulin, Chief Financial Officer.